Zhao Hubin
Biomedical Optics Research Laboratory, University College London, London WC1E 6BT, UK.
Int J Mol Sci. 2017 Aug 11;18(8):1751. doi: 10.3390/ijms18081751.
As a cell type-specific neuromodulation method, optogenetic technique holds remarkable potential for the realisation of advanced neuroprostheses. By genetically expressing light-sensitive proteins such as channelrhodopsin-2 (ChR2) in cell membranes, targeted neurons could be controlled by light. This new neuromodulation technique could then be applied into extensive brain networks and be utilised to provide effective therapies for neurological disorders. However, the development of novel optogenetic implants is still a key challenge in the field. The major requirements include small device dimensions, suitable spatial resolution, high safety, and strong controllability. In this paper, I present a concise review of the significant progress that has been made towards achieving a miniaturised, multifunctional, intelligent optogenetic implant. I identify the key limitations of current technologies and discuss the possible opportunities for future development.
作为一种细胞类型特异性神经调节方法,光遗传学技术在实现先进神经假体方面具有巨大潜力。通过在细胞膜中基因表达诸如通道视紫红质-2(ChR2)等光敏蛋白,可通过光来控制靶向神经元。然后,这种新的神经调节技术可应用于广泛的脑网络,并用于为神经疾病提供有效治疗。然而,新型光遗传学植入物的开发仍然是该领域的一项关键挑战。主要要求包括小尺寸设备、合适的空间分辨率、高安全性和强可控性。在本文中,我简要回顾了在实现小型化、多功能、智能光遗传学植入物方面所取得的重大进展。我确定了当前技术的关键局限性,并讨论了未来发展的可能机遇。